GlassScriptPhysician profile
Gil Q Galloway
NPI 1285783464
$7,188.23
in general payments reported to CMS, 2019-2025
10 companies · $16.00 in 2025
The $16.00 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,866 · 2020: $1,474 · 2021: $524 · 2022: $131 · 2023: $889 · 2024: $290 · 2025: $16.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $700 · Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $700.00 |
| Food and Beverage | $494.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,537.18 | 2019-2020 | |
| Davol INC. | $771.74 | 2019-2025 | Phasix Mesh |
| Medtronic, INC. | $700.00 | 2023 | |
| Covidien LP | $523.31 | 2019 | |
| Biotissue Holdings INC. | $334.75 | 2023-2024 | |
| Tela Bio, INC. | $146.10 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Wright Medical Technology, INC. | $70.16 | 2019-2020 | |
| Ethicon US, LLC | $61.39 | 2020-2023 | Ethicon |
| Baxter Healthcare | $24.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gil Galloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.